XML 29 R18.htm IDEA: XBRL DOCUMENT v3.20.2
Business Segments
9 Months Ended
Sep. 26, 2020
Segment Reporting [Abstract]  
Business Segments

11. Business Segments

The Company operates in one segment, ophthalmology. The Company develops, manufactures and markets medical devices. Our revenues arise from the sale of consoles, delivery devices, consumables, service, and support activities.

Revenue information shown by product group is as follows:

 

 

 

Three Months Ended

 

 

 

Nine Months Ended

 

(in thousands)

 

September 26, 2020

 

 

September 28, 2019

 

 

 

September 26, 2020

 

 

September 28, 2019

 

Cyclo G6

 

$

2,776

 

 

$

2,962

 

 

 

$

7,812

 

 

$

9,419

 

Retina

 

 

4,429

 

 

 

5,788

 

 

 

 

11,171

 

 

 

16,635

 

Other(1)

 

 

1,598

 

 

 

1,914

 

 

 

 

5,060

 

 

 

5,631

 

Total revenues

 

$

8,803

 

 

$

10,664

 

 

 

$

24,043

 

 

$

31,685

 

(1) Includes service contract revenues of $302 and $437 and $929 and $1,041 recognized during the three and nine months ended September 26, 2020 and September 28, 2019, respectively. Other also includes revenues from paid service, royalty, freight and legacy G probes.

 

 

Revenue information shown by geographic region, based on the sales destination, is as follows:

 

 

 

Three Months Ended

 

 

 

Nine Months Ended

 

(in thousands)

 

September 26, 2020

 

 

September 28, 2019

 

 

 

September 26, 2020

 

 

September 28, 2019

 

United States

 

$

5,269

 

 

$

5,833

 

 

 

$

12,881

 

 

$

16,362

 

Europe

 

 

1,913

 

 

 

2,112

 

 

 

 

5,316

 

 

 

7,176

 

Rest of Americas

 

 

599

 

 

 

735

 

 

 

 

1,221

 

 

 

2,107

 

Asia/Pacific Rim

 

 

1,022

 

 

 

1,984

 

 

 

 

4,625

 

 

 

6,040

 

Total revenues

 

$

8,803

 

 

$

10,664

 

 

 

$

24,043

 

 

$

31,685

 

 

Revenues are attributed to countries based on the location of end customers.

Other than the United States, no individual country accounted for more than 10% of the Company’s revenues during the three and nine months ended September 26, 2020.   Other than the United States, no individual country accounted for more than 10% of the Company’s revenues during the three and nine months ended September 28, 2019. The United States accounted for 59.9% and 54.7% of revenues for the three months ended September 26, 2020 and September 28, 2019, respectively. International sales accounted for 40.1% and 45.3% of revenues for the three months ended September 26, 2020 and September 28, 2019, respectively. For the nine months ended September 26, 2020 and September 28, 2019, the United States accounted for 53.6% and 51.6% of revenues, respectively. For the nine months ended September 26, 2020 and September 28, 2019, international sales accounted for 46.4% and 48.4% of revenues, respectively.